Sign In
Buy XPHYF
$0.284
+0 (+0%)
At Close: Apr 17, 2023
XPhyto Therapeutics adds mescaline production to its psychedelic medicine programs
08:34am, Wednesday, 10'th Feb 2021
XPhyto Therapeutics Corp (CSE:XPHYU) (OTCQB:XPHYF) (FRA:4XT) revealed on Wednesday that it has added the production of mescaline to its psychedelic medicine programs. Mescaline (3,4,5-trimethoxyphen
XPhyto Provides Comments on Promotional and Marketing Activity
08:40pm, Friday, 22'nd Jan 2021
VANCOUVER, BC / ACCESSWIRE / January 22, 2021 / XPhyto Therapeutics Corp . (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) ("XPhyto" or the "Corporation") at the request of OTC Markets, is providing the following c
XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact
05:00am, Monday, 18'th Jan 2021
Commercialization of rapid COVID-19 PCR test Clinical validation of transdermal and sublingual drug formulations Psychedelic API production, drug formulation and clinical integration VANCOUVER, BC / A
